Prosecution Insights
Last updated: April 19, 2026

Hinova Pharmaceuticals Inc.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17594474 Bifunctional chimeric heterocyclic compounds for targeted degradation of androgen receptors and use thereof COLEMAN, BRENDA LIBBY 1624 Final Rejection Oct 18, 2021

Managing Hinova Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month